Technical Support
(877) SEPAX-US, press 3      
TechSupport@sepax-tech.com

Representative Literature References

Click a row to open its literature reference.
Product PN Separation Mode
Broad Sample Type Specific Sample
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   Next   View All
Year Product PN Sep. Mode Broad Sample Category Specific Sample Title
2024Proteomix WAX-NP5404NP5-4605IEXMetalHexavalent Chromium Cr(VI)Development of a Fast Method Using Inductively Coupled Plasma Mass Spectrometry Coupled with High-Performance Liquid Chromatography and Exploration of the Reduction Mechanism of Cr(VI) in Foods
2024Proteomix SCX-NP3401NP3-4615IEXAntibodyMonoclonal AntibodiesOnline Multimethod Platform for Comprehensive Characterization of Monoclonal Antibodies in Cell Culture Fluid a Single Sample Injection - Intact Protein Workflow
2024SRT SEC-1000215950-7815SECNanoparticleMosaic InfluenzaMosaic Quadrivalent Influenza Vaccine Single Nanoparticle Characterization
2024SRT SEC-500215500-4630SECAntibodyComplex with mAbCharacterization of Large Immune Complexes with Size Exclusion Chromatography and Native Mass Spectrometry Supplemented with Gas Phase Ion Chemistry
2024Bio C-18106185-4625RPNanoparticlePEGylated Mesoporous Silica NanoparticlesOvercoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma
2024Unix-C SEC-300231300-4615SECAntibodyHIV-1 Env AntibodyAbsolute quantitation of binding antibodies from clinical samples
2024Zenix-C SEC-300233300-7830SECMembrane ProteinGPCRStructural insights into CXCR4 modulation and oligomerization
2023Proteomix HIC Butyl-NP5N/AHICAntibodyMAbAntibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
2023SRT-10 SEC-300225300-21230SECProteinN/AResurrecting ancestral antibiotics: unveiling the origins of modern lipid II targeting glycopeptides
2023SRT SEC-1000215950-30030SECDNA/RNA/OLIGOcircRNACircular mRNA-based TCR-T offers a safe and effective therapeutic strategy for treatment of cytomegalovirus infection
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   Next   View All
© 2024 Sepax Technologies, Inc. All Rights Reserved.